Resolute vice-president Beatrice Evangelista will lead client services for this office.
‘Pennsylvania makes strategic business sense for Resolute's rapid and future growth in the United States,' said Evangelista. ‘This is one of the geographic centres that represent the future of healthcare communications opportunities, with its numerous medical and academic centres, biotech and pharma companies, and device, diagnostic and health technology organisations.'
Resolute joint chief executive and founding partner Paul Blackburn said: ‘This expansion is a timely milestone to our diversification and demonstrates our increased investment in meeting the needs of the continuously growing healthcare market in this region.'
Pennsylvania currently ranks fourth in the US among all states in bioscience academic R&D expenditures and fourth in total research awards from the National Institutes of Health in 2007.
